Empfehlungen zum Einsatz von Abatacept bei Patienten mit rheumatoider Arthritis

被引：2
作者：
Krueger, K. [1 ]
Gaubitz, M. [2 ]
机构：
[1] Praxiszent St Bonifatius, D-81541 Munich, Germany
[2] Univ Klinikum Munster, Munster, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2008年 / 67卷 / 07期
关键词：
D O I：
10.1007/s00393-008-0347-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：614 / 616
页数：3
相关论文
共 12 条
[1]   Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 [J].
Furst, D. E. ;
Breedveld, F. C. ;
Kalden, J. R. ;
Smolen, J. S. ;
Burmester, G. R. ;
Sieper, J. ;
Emery, P. ;
Keystone, E. C. ;
Schiff, M. H. ;
Mease, P. ;
van Riel, P. L. C. M. ;
Fleischmann, R. ;
Weisman, M. H. ;
Weinblatt, M. E. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 :2-22
[2]   Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition [J].
Genovese, MC ;
Becker, J ;
Schiff, M ;
Luggen, M ;
Sherrer, Y ;
Kremer, J ;
Birbara, C ;
Box, J ;
Natarajan, K ;
Nuamah, I ;
Li, T ;
Aranda, R ;
Hagerty, DT ;
Dougados, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (11) :1114-1123
[3]  
Haggerty HG, 2007, J RHEUMATOL, V34, P2365
[4]   Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial [J].
Kremer, JM ;
Dougados, M ;
Emery, P ;
Durez, P ;
Sibilia, J ;
Shergy, W ;
Steinfeld, S ;
Tindall, E ;
Becker, JC ;
Li, T ;
Nuamah, IF ;
Aranda, R ;
Moreland, LW .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2263-2271
[5]   Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial [J].
Kremer, Joel M. ;
Genant, Harry K. ;
Moreland, Larry W. ;
Russell, Anthony S. ;
Emery, Paul ;
Abud-Mendoza, Carlos ;
Szechinski, Jacek ;
Li, Tracy ;
Ge, Zhiyu ;
Becker, Jean-Claude ;
Westhovens, Rene .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :865-876
[6]   Gaucher disease, Fabry disease and mucopolysaccharidosis type I - How can the rheumatologist recognise these patients? [J].
Manger, B ;
Mengel, E ;
Schaefer, R ;
Haase, C ;
Seidel, J ;
Michels, H .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (01) :32-+
[7]   Costimulatory blockade in patients with rheumatoid arthritis a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion [J].
Moreland, LW ;
Alten, R ;
Van den Bosch, F ;
Appelboom, T ;
Leon, M ;
Emery, P ;
Cohen, S ;
Luggen, M ;
Shergy, W ;
Nuamah, I ;
Becker, JC .
ARTHRITIS AND RHEUMATISM, 2002, 46 (06) :1470-1479
[8]  
RUBBERT A, 2008, Z RHEUMATOL IN PRESS
[9]   Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials [J].
Salliot, C. ;
Dougados, M. ;
Gossec, L. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (01) :25-32
[10]  
SCHIFF M, 2007, ANN RHEUM DIS
12